SCHEMBL24287257

SCHEMBL24287257

Cc1cc(C)c(Oc2nc3ccccc3nc2C)c(C)c1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ CRHR1 P34998 3/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ NQO2 P16083 2/20 0.42
▸ KDM4E B2RXH2 4/20 0.42
▸ HPGD P15428 2/20 0.42
▸ PSMB5 P28074 1/20 0.41
▸ GAA P10253 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ STAT3 P40763 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24287259 0.81 GAA (0.56) SMN1; SMN2L3MBTL1TSHRNQO2KDM4E
SCHEMBL26813126 0.81 CRHR1 (0.44) SMN1; SMN2CRHR1NQO2KDM4EHPGD
SCHEMBL24287258 0.77 ALDH1A1 (0.50) SMN1; SMN2L3MBTL1TSHRNQO2KDM4E
SCHEMBL26817460 0.72 KDM4E (0.60) TSHRKDM4EHPGDGAAALDH1A1
SCHEMBL18796236 0.72 NQO2 (0.44) SMN1; SMN2L3MBTL1TSHRNQO2KDM4E
SCHEMBL804981 0.71 TSHR (0.61) SMN1; SMN2L3MBTL1TSHRNQO2KDM4E
SCHEMBL18796404 0.70 LCK (0.52) SMN1; SMN2L3MBTL1TSHRNQO2KDM4E
SCHEMBL18796088 0.70 L3MBTL1 (0.47) SMN1; SMN2L3MBTL1TSHRNQO2KDM4E
SCHEMBL16795314 0.70 ALDH1A1 (0.54) SMN1; SMN2L3MBTL1TSHRKDM4EHPGD
SCHEMBL8460913 0.69 CRHR1 (0.48) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076629-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback